Small Cap Losers: Oi SA (NYSE:OIBR), Scientific Games Corp (NASDAQ:SGMS), Gafisa SA (NYSE:GFA), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Oi S.A. (ADR) (NYSE:OIBR) announces to its shareholders and the market in general that it filed the preliminary prospectus supplement relating to the Offering (as defined below) with the U.S. Securities and Exchange Commission on the date hereof. Oi SA (ADR) (NYSE:OIBR) shares after opening at $ 1.26 moved to $1.26 on last trade day and at the end of the day closed at $1.15. Company price to sales ratio in past twelve months was calculated as 0.14. Oi SA (ADR) (NYSE:OIBR) showed a negative weekly performance of -18.44%.

Scientific Games Corp. (NASDAQ:SGMS) saw a large decrease in short interest during the month of January. As of March 31st, there was short interest totalling 3,537,157 shares, a decrease of 41.0% from the March 14th total of 5,995,735 shares, Analyst RN reports. Scientific Games Corp (NASDAQ:SGMS) shares fell -5.99% in last trading session and ended the day on $11.15. SGMS return on equity ratio is recorded as -16.10% and its return on assets is -2.00%. Scientific Games Corp (NASDAQ:SGMS) yearly performance is 34.82%.

Gafisa S.A. (ADR) (NYSE:GFA), Brazil’s leading diversified national homebuilder, reported financial results for the fourth quarter ended December 31, 2013. Gafisa SA (ADR) (NYSE:GFA) shares moved up 3.34% in last trading session and was closed at $3.15 while trading in range of $3.12 – $3.34 – Gafisa SA (ADR) (NYSE:GFA) year to date (YTD) performance is 0.64%.

Corcept Therapeutics, Inc. (NASDAQ:CORT) entered into a manufacturing agreement (the “Agreement”) with AAIPharma Services Corp. (“AAI”), pursuant to which AAI will manufacture and package Korlym®tablets (the “product”). We will supply mifepristone, the active pharmaceutical ingredient in Korlym®, to AAI for use in the manufacture of the product. Corcept Therapeutics Incorporated (NASDAQ:CORT) weekly performance is -18.66%. On last trading day company shares ended up $3.40. Corcept Therapeutics Incorporated (NASDAQ:CORT) distance from 50-day simple moving average (SMA50) is -7.74%. Analysts mean target price for the company is $3.50.